Cargando…

Clinical characteristics and prognoses of pulmonary mucormycosis in four children

IMPORTANCE: Pulmonary mucormycosis is life threatening and carries a poor prognosis. Identification of factors that improve prognosis is urgently necessary. OBJECTIVE: To analyze the clinical features and outcomes of pulmonary mucormycosis in children. METHODS: A retrospective analysis of clinical d...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Siyuan, Liu, Hui, Tang, Xiaolei, Yang, Haiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331397/
https://www.ncbi.nlm.nih.gov/pubmed/32851327
http://dx.doi.org/10.1002/ped4.12161
_version_ 1783553320589197312
author Guo, Siyuan
Liu, Hui
Tang, Xiaolei
Yang, Haiming
author_facet Guo, Siyuan
Liu, Hui
Tang, Xiaolei
Yang, Haiming
author_sort Guo, Siyuan
collection PubMed
description IMPORTANCE: Pulmonary mucormycosis is life threatening and carries a poor prognosis. Identification of factors that improve prognosis is urgently necessary. OBJECTIVE: To analyze the clinical features and outcomes of pulmonary mucormycosis in children. METHODS: A retrospective analysis of clinical data of four cases with pulmonary mucormycosis was conducted in Beijing Children's Hospital from January 2017 to December 2018. RESULTS: Underlying diseases were identified in all four cases (diabetes in three individuals and a hematological malignancy in one individual). The predominant clinical manifestations were fever, cough, chest pain and hemoptysis. Imaging features included consolidation or nodules with cavities. All four cases were treated with liposomal amphotericin B, one case underwent lobectomy, and three cases received a full course of posaconazole. All four cases were cured. INTERPRETATION: Patients with pulmonary mucormycosis often have underlying diseases. Imaging features are relatively characteristic. Treatment with liposomal amphotericin B at an early stage and a sufficient course of posaconazole for maintenance significantly improves prognosis.
format Online
Article
Text
id pubmed-7331397
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-73313972020-08-25 Clinical characteristics and prognoses of pulmonary mucormycosis in four children Guo, Siyuan Liu, Hui Tang, Xiaolei Yang, Haiming Pediatr Investig Clinical Experience IMPORTANCE: Pulmonary mucormycosis is life threatening and carries a poor prognosis. Identification of factors that improve prognosis is urgently necessary. OBJECTIVE: To analyze the clinical features and outcomes of pulmonary mucormycosis in children. METHODS: A retrospective analysis of clinical data of four cases with pulmonary mucormycosis was conducted in Beijing Children's Hospital from January 2017 to December 2018. RESULTS: Underlying diseases were identified in all four cases (diabetes in three individuals and a hematological malignancy in one individual). The predominant clinical manifestations were fever, cough, chest pain and hemoptysis. Imaging features included consolidation or nodules with cavities. All four cases were treated with liposomal amphotericin B, one case underwent lobectomy, and three cases received a full course of posaconazole. All four cases were cured. INTERPRETATION: Patients with pulmonary mucormycosis often have underlying diseases. Imaging features are relatively characteristic. Treatment with liposomal amphotericin B at an early stage and a sufficient course of posaconazole for maintenance significantly improves prognosis. John Wiley and Sons Inc. 2019-12-21 /pmc/articles/PMC7331397/ /pubmed/32851327 http://dx.doi.org/10.1002/ped4.12161 Text en © 2019 Chinese Medical Association. Pediatric Investigation published by John Wiley & Sons Australia, Ltd on behalf of Futang Research Center of Pediatric Development. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Clinical Experience
Guo, Siyuan
Liu, Hui
Tang, Xiaolei
Yang, Haiming
Clinical characteristics and prognoses of pulmonary mucormycosis in four children
title Clinical characteristics and prognoses of pulmonary mucormycosis in four children
title_full Clinical characteristics and prognoses of pulmonary mucormycosis in four children
title_fullStr Clinical characteristics and prognoses of pulmonary mucormycosis in four children
title_full_unstemmed Clinical characteristics and prognoses of pulmonary mucormycosis in four children
title_short Clinical characteristics and prognoses of pulmonary mucormycosis in four children
title_sort clinical characteristics and prognoses of pulmonary mucormycosis in four children
topic Clinical Experience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331397/
https://www.ncbi.nlm.nih.gov/pubmed/32851327
http://dx.doi.org/10.1002/ped4.12161
work_keys_str_mv AT guosiyuan clinicalcharacteristicsandprognosesofpulmonarymucormycosisinfourchildren
AT liuhui clinicalcharacteristicsandprognosesofpulmonarymucormycosisinfourchildren
AT tangxiaolei clinicalcharacteristicsandprognosesofpulmonarymucormycosisinfourchildren
AT yanghaiming clinicalcharacteristicsandprognosesofpulmonarymucormycosisinfourchildren